Apart from the active substances the placebo is identical to the IMP clinical trials

TSPO ligands in the treatment of depression: proof-of-concept of efficacy and underlying mechanisms of action

This study is testing a new capsule treatment for different types of depression. Researchers want to see if it helps improve mood and understand how it works in the body. It's an early-stage study open to adults aged 18 and over.